Metaverse Dualchain Network Architecture (DNA) Price Up 0% T

Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 186,200 shares, a growth of 51.4% from the March 31st total of 123,000 shares. Based on an average daily trading volume, of 78,500 shares, the days-to-cover ratio […]

Related Keywords

Frank Karbe , Geoffreym Parker , Exchange Commission , Securities Exchange Commission , Better Therapeutics Inc , Nasdaq , Better Therapeutics , Get Rating , Street Capital , Lifesci Capital , Director Geoffrey , Street Corp , Better Therapeutics Daily , Nasdaq Bttx , Bttx , Medical , Stocks , Options , Put , Call ,